Literature DB >> 11329147

Expression of neurotrophins and their receptors in pigment cell lesions of the skin.

P F Innominato1, L Libbrecht, J J van den Oord.   

Abstract

The neurotrophins (NTs) are a group of growth factors involved in the development of the nervous system and presumed to play a role in neural crest-derived tumours. The expression of three NTs (NGF, BDNF, and NT-3) and their receptors (NTRs; i.e. low-affinity pan-NT receptor p75, Trk-B, and Trk-C) was studied in frozen sections of benign and malignant cutaneous pigment cell lesions, using immunohistochemistry. In order to understand the possible role of these growth factors and their receptors in the progression of primary cutaneous malignant melanomas (PCMMs), their distribution in the radial (RGP) and vertical (VGP) growth phases was particularly studied. While most of the common acquired naevi were unreactive, Spitz and blue naevi showed scattered immunoreactive cells, especially for the p75 NTR. Dysplastic naevi, but not common naevi, expressed NT-3 in their junctional component. PCMM and melanoma metastases often showed a diffuse pattern of immunostaining. NT-3 was significantly more frequently expressed in the RGP of PCMMs than in the junctional component of benign naevi, whereas more extensive immunoreactivity for NGF was found in the VGP of PCMMs, compared with the RGP; metastases more frequently expressed NGF, BDNF, and Trk-B than PCMMs. Interestingly, neurotropic melanoma expressed all NTs/NTRs except Trk-B. These immuunohistochemical data confirm suggestions from previous in vitro studies that autocrine loops of certain NTs and their respective receptors may be involved in melanoma progression; in addition, NT-3 may be involved in the junctional growth of dysplastic naevi. The precise role of these growth factors in melanoma, however, will await further functional studies. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11329147     DOI: 10.1002/path.861

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

Review 1.  Neurotrophins and the immune system.

Authors:  José A Vega; Olivia García-Suárez; Jonas Hannestad; Marta Pérez-Pérez; Antonino Germanà
Journal:  J Anat       Date:  2003-07       Impact factor: 2.610

2.  Molecular classification and subtype-specific characterization of skin cutaneous melanoma by aggregating multiple genomic platform data.

Authors:  Xiaofan Lu; Qianyuan Zhang; Yue Wang; Liya Zhang; Huiling Zhao; Chen Chen; Yaoyan Wang; Shengjie Liu; Tao Lu; Fei Wang; Fangrong Yan
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-11       Impact factor: 4.553

Review 3.  Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.

Authors:  Tura C Camilli; Ashani T Weeraratna
Journal:  Biochem Pharmacol       Date:  2010-03-06       Impact factor: 5.858

4.  Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.

Authors:  Bonnie E Gould Rothberg; David L Rimm
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

5.  Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis.

Authors:  Jimena Bouzas-Rodriguez; Jorge Ruben Cabrera; Céline Delloye-Bourgeois; Gabriel Ichim; Jean-Guy Delcros; Marie-Anne Raquin; Raphaël Rousseau; Valérie Combaret; Jean Bénard; Servane Tauszig-Delamasure; Patrick Mehlen
Journal:  J Clin Invest       Date:  2010-02-15       Impact factor: 14.808

6.  Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study.

Authors:  Jian-Jun Du; Ke-Feng Dou; Shu-You Peng; Bing-Zhi Qian; Hua-Sheng Xiao; Feng Liu; Wei-Zhong Wang; Wen-Xian Guan; Zhi-Qing Gao; Ying-Bin Liu; Ze-Guang Han
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 7.  Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

Authors:  Bonnie E Gould Rothberg; Michael B Bracken; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

8.  Double-targeting using a TrkC ligand conjugated to dipyrrometheneboron difluoride (BODIPY) based photodynamic therapy (PDT) agent.

Authors:  Anyanee Kamkaew; Kevin Burgess
Journal:  J Med Chem       Date:  2013-09-24       Impact factor: 7.446

9.  Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression.

Authors:  Léon C van Kempen; Karin van den Hurk; Vladimir Lazar; Stefan Michiels; Véronique Winnepenninckx; Marguerite Stas; Alan Spatz; Joost J van den Oord
Journal:  Virchows Arch       Date:  2012-09-06       Impact factor: 4.064

10.  Upregulated ankyrin repeat-rich membrane spanning protein contributes to tumour progression in cutaneous melanoma.

Authors:  Y H Liao; S M Hsu; H L Yang; M S Tsai; P H Huang
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.